295 results on '"Jungner, Ingmar"'
Search Results
2. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
3. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study
4. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
5. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
6. Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
7. Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow-up in a large cohort: The Värmland survey
8. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
9. Iron metabolism and risk of cancer in the Swedish AMORIS study
10. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort
11. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
12. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
13. Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
14. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study
15. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients
16. Relation of Age, the Apolipoprotein B/Apolipoprotein A-I Ratio, and the Risk of Fatal Myocardial Infarction and Implications for the Primary Prevention of Cardiovascular Disease
17. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
18. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis
19. Does Low-Density Lipoprotein Size Add to Atherogenic Particle Number in Predicting the Risk of Fatal Myocardial Infarction?
20. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study
21. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
22. Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
23. Prostate cancer risk in the Swedish AMORIS study: The interplay among triglycerides, total cholesterol, and glucose
24. Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
25. Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
26. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
27. Additional file 1: of Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
28. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy
29. Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females
30. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
31. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
32. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
33. Additional file 1: of Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
34. Additional file 1: of Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
35. Additional file 2: of Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
36. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
37. Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
38. Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study
39. Serum inflammatory markers in relation to prostate cancer severity and death
40. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
41. Serum inflammatory markers in relation to prostate cancer severity and death
42. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
43. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
44. Gunnar Jungner and the Principles and Practice of Screening for Disease
45. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort
46. Serum inflammatory markers and colorectal cancer risk and survival
47. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
48. Cohort Profile: The AMORIS cohort
49. Association between metabolic syndrome components and the risk of primary liver cancer and cirrhosis
50. Additional file 1: of Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.